In addition to the importance of the clarification of this pathway inhibition mechanism by TcdA in C. difficile infection, targeting Rac-1 with TcdA, which resulted in the Wnt/β-catenin pathway and cell proliferation inhibition, may be one strategy to control tumor growth. This evidence concerns the gene RAC1 and neoplasm.